Status:
UNKNOWN
Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine
Lead Sponsor:
Chinese Academy of Medical Sciences
Collaborating Sponsors:
Guangxi Center for Disease Control and Prevention
Conditions:
Poliomyelitis
Eligibility:
All Genders
24-48 years
Phase:
PHASE3
Brief Summary
Trail To Evaluate the Immunity Duration of healthy children who already took part in " The safety and immunogenicity by different sequential schedules of bOPV and bOPV in dragee candy with sIPV, a ran...
Detailed Description
According to the requirement of the Strategy of Polio Eradication \& Endgame Strategic Plan 2013-2018, bivalent oral attenuated live poliomyelitis vaccine against type 1 and 3 (bOPV) and inactivated p...
Eligibility Criteria
Inclusion
- Subjects who have already taken part in phase 3 clinical trail in Guangxi and were vaccinated 3-dose primary immunization with polio vaccines .Moreover，the results of the selected paired serum are required.
- 24 months old(calendar month).
- Guardians understand the contents and requirements of this trail , meanwhile, voluntarily joined this study with informed consents.
- Able to attend all scheduled visits and to comply with all trial procedures(including vaccinate and blood collection)
Exclusion
- Any booster immunization with polio vaccine after finishing 3-dose primary immunizations research.
- Polio virus infection was demonstrated in laboratory experiment.
- Participation in another clinical trial at the same times.
- Any condition that in the opinion of the investigator, may interfere with the evaluation of study objectives or increase the risk of subjects,such as acute or chronic diseases 、some abnormal detected by lab,and so on.
Key Trial Info
Start Date :
January 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
1165 Patients enrolled
Trial Details
Trial ID
NCT03821441
Start Date
January 4 2018
End Date
August 1 2020
Last Update
January 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangxi Provincial Center for Diseases Control and Prevention
Nanning, Guangxi, China